XVIVO Perfusion AB (publ) has decided to postpone the publication of its interim report for the period January–March 2026. The interim report will be published on Friday, 24 April 2026, instead of the previously communicated date of Wednesday, 22 April 2026.
The change is due to the fact that the previously announced reporting date coincides with the presentation of XVIVO’s U.S. heart preservation study, PRESERVE, at the ISHLT conference in Toronto.
Molndal, February 10, 2026
XVIVO Perfusion AB (publ)